These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25638840)
21. Comparison of the safety and efficacy of biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents: propensity score-matched analysis. Lee JH; Lee JW; Youn YJ; Ahn MS; Ahn SG; Kim JY; Yoo BS; Lee SH; Choi E; Yoon J J Interv Cardiol; 2014 Aug; 27(4):399-407. PubMed ID: 25052960 [TBL] [Abstract][Full Text] [Related]
22. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial. Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Puricel S; Slagboom T; Goy JJ; den Heijer P; van der Ent M EuroIntervention; 2015 Jul; 11(3):272-9. PubMed ID: 26196753 [TBL] [Abstract][Full Text] [Related]
24. Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention. Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Int Heart J; 2020 Jul; 61(4):673-684. PubMed ID: 32684595 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus. Waksman R; Shlofmitz E; Windecker S; Koolen JJ; Saito S; Kandzari D; Kolm P; Lipinski MJ; Torguson R Am J Cardiol; 2019 Oct; 124(7):1020-1026. PubMed ID: 31353004 [TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography. Tada T; Kastrati A; Byrne RA; Schuster T; Cuni R; King LA; Cassese S; Joner M; Pache J; Massberg S; Schömig A; Mehilli J Int J Cardiovasc Imaging; 2014 Mar; 30(3):495-504. PubMed ID: 24452729 [TBL] [Abstract][Full Text] [Related]
27. Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y PLoS One; 2018; 13(10):e0205046. PubMed ID: 30289945 [TBL] [Abstract][Full Text] [Related]
28. Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations. Costopoulos C; Latib A; Naganuma T; Sticchi A; Ferrarello S; Regazzoli D; Chieffo A; Figini F; Carlino M; Montorfano M; Naim C; Kawaguchi M; Gerasimou A; Giannini F; Godino C; Colombo A Catheter Cardiovasc Interv; 2014 May; 83(6):889-95. PubMed ID: 23804318 [TBL] [Abstract][Full Text] [Related]
29. Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial. Natsuaki M; Watanabe H; Morimoto T; Kozuma K; Kadota K; Muramatsu T; Nakagawa Y; Akasaka T; Hanaoka KI; Tanabe K; Morino Y; Ishikawa T; Katoh H; Nishikawa H; Tamura T; Ono K; Yamamoto K; Ishihara T; Abe M; Taniguchi R; Ikari Y; Okada K; Kimura T EuroIntervention; 2023 Aug; 19(5):e402-e413. PubMed ID: 37395475 [TBL] [Abstract][Full Text] [Related]
30. The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS). Wykrzykowska J; Serruys P; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; Di Mario C; Van Geuns RJ; Van Es GA; Juni P; Windecker S EuroIntervention; 2011 Nov; 7(7):789-95. PubMed ID: 22027687 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis. Choe JC; Cha KS; Jang HY; Choi JH; Kim BW; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Ahn Y; Jeong MH; Angiology; 2017 Sep; 68(8):698-706. PubMed ID: 27872316 [TBL] [Abstract][Full Text] [Related]
32. Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials. Bundhun PK; Janoo G; Yanamala CM; Huang F Medicine (Baltimore); 2017 Jul; 96(28):e7510. PubMed ID: 28700502 [TBL] [Abstract][Full Text] [Related]
33. Comparison of coronary angioscopic findings 8 months after stent implantation between two kinds of biodegradable polymer-coated and one durable polymer-coated drug-eluting stent. Yasumura K; Shutta R; Matsunaga-Lee Y; Nakamura D; Yano M; Yamato M; Egami Y; Sakata Y; Nishino M; Tanouchi J Coron Artery Dis; 2021 Mar; 32(2):91-95. PubMed ID: 32976243 [TBL] [Abstract][Full Text] [Related]
34. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI. Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937 [TBL] [Abstract][Full Text] [Related]
35. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419 [TBL] [Abstract][Full Text] [Related]
36. Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study. Matsuda H; Kagase A; Tokuda T; Ochiumi Y; Murata A; Suzuki Y; Ito T J Interv Cardiol; 2020; 2020():2869303. PubMed ID: 32395090 [TBL] [Abstract][Full Text] [Related]
37. Long-term comparison of everolimus-eluting and biolimus-eluting stents. Puricel S; Oberhänsli M; Guntern P; Lehmann S; Goy JJ; Arroyo D; Villeneuve H; Baeriswyl G; Stauffer JC; Togni M; Cook S EuroIntervention; 2013 Jul; 9(3):336-44. PubMed ID: 23482296 [TBL] [Abstract][Full Text] [Related]
38. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372 [TBL] [Abstract][Full Text] [Related]
39. 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice. Klauss V; Serruys PW; Pilgrim T; Buszman P; Linke A; Ischinger T; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; van Geuns RJ; van Es GA; Kalesan B; Wenaweser P; Jüni P; Windecker S JACC Cardiovasc Interv; 2011 Aug; 4(8):887-95. PubMed ID: 21851904 [TBL] [Abstract][Full Text] [Related]
40. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model. Sumida A; Gogas BD; Nagai H; Li J; King SB; Chronos N; Hou D Cardiovasc Revasc Med; 2015 Sep; 16(6):351-7. PubMed ID: 26294337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]